Ethosuximide
Specifications
77-67-8CAS Number
201-048-7EC Number
3-ethyl-3-methylpyrrolidine-2,5-dioneIUPAC Name
C7H11NO2Chemical Formula
141.17 g/molMolecular Weight
ethosuximide; 77-67-8; Zarontin; Etosuximida; 2-Ethyl-2-methylsuccinimide; 3-Ethyl-3-methylpyrrolidine-2,5-dione; Ethosuxide; Pyknolepsinum; Emeside; Suxilep; Ethosuccimide; Ethosuccinimide; Atysmal; Suxinutin; Etosuximid; Petinimid; Zarondan; Aethosuximide; Thilopemal; 3-Ethyl-3-methyl-2,5-pyrrolidinedione; Ethosuximidum; 3-Methyl-3-ethylsuccinimide; CI-366; 2-Methyl-2-ethylsuccinimide; PM-671; 2,5-Pyrrolidinedione, 3-ethyl-3-methyl-; 3-Ethyl-3-methylsuccinimide; Etosuccimide; Succinimide, 2-ethyl-2-methyl-; CN-10,395; PM 671; alpha-Ethyl-alpha-methylsuccinimide; alpha-Methyl-alpha-ethylsuccinimide; 3-Methyl-3-ethylpyrrolidine-2,5-dione; gamma-Methyl-gamma-ethyl-succinimide; CN-10395; NSC-64013; DTXSID7023019; H 940; H-490; (+-)-2-Ethyl-2-methylsuccinimide; gamma-ethyl-gamma-methyl-succinimide; 5SEH9X1D1D; CI 366; NSC64013; CHEBI:4887; DTXCID203019; Ethosuccimid; Ethylmethylsuccimide; Faes, Etosuximida; 3-ethyl-5-hydroxy-3-methyl-3,4-dihydro-2H-pyrrol-2-one; RefChem:56507; N03AD01; (2RS)-2-Ethyl-2-methylsuccinimide; 201-048-7; Petnidan; Capitus; Ethymal; Ronton; Pentinimid; Peptinimid; Succimitin; Zaraondan; Mesentol; Pemalin; Simatin; Succimal; Suximal; Thetamid; Zarodan; Zartalin; Asamid; Etomal; Pemal; Suxin; Epileo Petit MAL; Piknolepsin; Zarondan-Saft; Simatin(E); C.I. 366; Cl 366; 3-ethyl-3-methyl-pyrrolidine-2,5-dione; MFCD00072123; 3-Ethyl-3-methylpyrroline-2,5-dione; CHEMBL696; .alpha.-Ethyl-.alpha.-methylsuccinimide; Aethosuccimidum; Etosuximide; (+/-)-2-ethyl-2-methylsuccinimide; s4626; .gamma.-Methyl-.gamma.-ethylsuccinimide; Etosuccimide [DCIT]; Aethosuximide [German]; N-Ethyl methylsuccinimide; Ethosuximidum [INN-Latin]; Etosuximida [INN-Spanish]; Pyknole.psi.num; Piknole.psi.n; Zarontin (TN); HSDB 1119; SR-01000075863; EINECS 201-048-7; NSC 64013; UNII-5SEH9X1D1D; BRN 0117054; Ethosuximide RS; Ethosuximide CRS; CAS-77-67-8; NCGC00016320-01; Prestwick_611; Ethosuximide [USAN:USP:INN:BAN:JAN]; Spectrum_001385; Ethosuximide (Standard); Prestwick0_000165; Prestwick1_000165; Prestwick2_000165; Prestwick3_000165; Spectrum2_001483; Spectrum3_000944; Spectrum4_001051; Spectrum5_001073; ETHOSUXIMIDE [MI]; E0746; (.+/-.)-Ethosuximide; ETHOSUXIMIDE [INN]; ETHOSUXIMIDE [JAN]; 2, 3-ethyl-3-methyl-; E 7138; ETHOSUXIMIDE [HSDB]; ETHOSUXIMIDE [USAN]; ETHOSUXIMIDE [VANDF]; NCIOpen2_000014; Lopac0_000532; SCHEMBL34212; BSPBio_000029; ETHOSUXIMIDE [MART.]; KBioGR_001342; KBioSS_001865; 5-21-09-00595 (Beilstein Handbook Reference); DivK1c_000218; ETHOSUXIMIDE [USP-RS]; ETHOSUXIMIDE [WHO-DD]; ETHOSUXIMIDE [WHO-IP]; SPECTRUM1502196; 2,5-Pyrrolidinedione, 3-ethyl-3-methyl-, (+-)-; SPBio_001465; SPBio_001950; BPBio1_000033; GTPL7182; orb1224020; orb1310343; orb3141260; WLN: T5VMVTJ D2 D1; SCHEMBL20541518; Ethosuximide (JP18/USP/INN); Ethosuximide, analytical standard; HMS500K20; HY-B1378R; KBio1_000218; KBio2_001865; KBio2_004433; KBio2_007001; KBio3_002008; NINDS_000218; ETHOSUXIMIDE [ORANGE BOOK]; GLXC-06110; HMS1568B11; HMS1921L14; HMS2092D20; HMS2095B11; HMS3261L05; HMS3712B11; HMS3885D12; HMS5083G04; Pharmakon1600-01502196; ETHOSUXIMIDE [EP MONOGRAPH]; HY-B1378; MSK10713; ETHOSUXIMIDE [USP MONOGRAPH]; Ethosuximide 1.0 mg/ml in Methanol; Tox21_110370; Tox21_500532; BDBM50240424; CCG-39217; EBC-03155; ETHOSUXIMIDUM [WHO-IP LATIN]; NSC758192; 3-ethyl-3-methylazolidine-2,5-dione; AKOS005261742; Tox21_110370_1; CS-7976; DB00593; FE22867; LP00532; NSC-758192; SDCCGSBI-0050515.P004; .alpha.-Methyl-.alpha.-ethylsuccinimide; IDI1_000218; NCGC00015418-02; NCGC00015418-03; NCGC00015418-04; NCGC00015418-05; NCGC00015418-06; NCGC00015418-08; NCGC00015418-09; NCGC00015418-12; NCGC00015418-15; NCGC00093923-01; NCGC00093923-02; NCGC00093923-03; NCGC00093923-04; NCGC00261217-01; 3-Ethyl-3-methyl-2, 5-pyrrolidinedione; AS-16859; DA-63296; SBI-0050515.P003; 2, 5-Pyrrolidinedione, 3-ethyl-3-methyl-; AB00052288; EU-0100532; NS00010826; ST51037248; (RS)-3-Ethyl-3-methylpyrrolidine-2,5-dione; C07505; D00539; D70258; EN300-123801; AB00052288_04; zarontin3-Ethyl-3-methyl-pyrrolidine-2,5-dione; F806938; Q421567; SR-01000075863-1; SR-01000075863-3; SR-01000075863-5; 3-Ethyl-3-methyl-pyrrolidine-2,5-dione(Ethosuximide); BRD-A99633051-001-04-7; BRD-A99633051-001-05-4; BRD-A99633051-001-07-0; BRD-A99633051-001-08-8; 3-Ethyl-3-methyl-pyrrolidine-2,5-dione (ethosuximide); Z384975088; 4-ethyl-5-hydroxy-4-methyl-3,4-dihydro-2H-pyrrol-2-one; 2,5-PYRROLIDINEDIONE, 3-ETHYL-3-METHYL-, (+/-)-; Ethosuximide, European Pharmacopoeia (EP) Reference Standard; Ethosuximide, United States Pharmacopeia (USP) Reference StandardSynonyms
